Fabrice Le Gall

This inventor holds 8 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 8 EPO patents. Top assignees: Affimed Gmbh, Astellas Pharma Gmbh, Biontech Ag. Active years: 2011-2023.

USPTO Granted Patents = 8 (Patent Applications = 10)

% Patents Active = 75.0

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 48(Granted Patents)

Location History:

Edingen-Neckarhausen, DE (2011 - 2017)
Mainz, DE (2018 - 2023)

Company Filing History:

Affimed Therapeutics, Ag

Ganymed Pharmaceuticals Ag

patents

7. 1 out of 10

Ganymed Pharmaceuticals Gmbh

Tron—translationale Onkologic an Der Universitätsmedzin Der Johannes Gutenberg-Universität Mainz Gemcinnützige Gmbh

patent

10. 1 out of 25

Tron—translationale Onkologie an Der Universitátsmedizin Der Johannes Gutenberg—universität Mainz Gemeinnützige Gmbh

patents

11. 1 out of 18

Universitätsmedizin Der Johannes Gutenberg-Universitat Mainz

patents

where one patent can have more than one assignee

Years Active: 2011-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11787862 - Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for treatment of Claudin expressing cancer diseases (2023-10-17),

2. 11541127 - Drug conjugates comprising antibodies against claudin 18.2 (2023-01-03),

3. 10717780 - Agents for treatment of claudin expressing cancer diseases (2020-07-21),

4. 10093736 - Agents for treatment of claudin expressing cancer diseases (2018-10-09),

5. 9701750 - Anti-CD16 binding molecules (2017-07-11),

6. 9226962 - Human CD3-specific antibody with immunosuppressive properties (2016-01-05),

7. 9035026 - Anti-CD16 binding molecules (2015-05-19),

8. 7901677 - Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types (2011-03-08),

Title: The Innovative Journey of Fabrice Le Gall

Introduction: Fabrice Le Gall is a renowned inventor based in Mainz, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Fabrice Le Gall holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Fabrice Le Gall has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation. His work has significantly impacted the fields of robotics, sustainable technologies, and healthcare.

Collaborations: Throughout his career, Fabrice Le Gall has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence. His collaborative projects have resulted in cutting-edge solutions that have garnered international recognition.

Conclusion: Fabrice Le Gall's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in Mainz, Germany, and beyond. His work continues to inspire the next generation of inventors and shape the future of technology.